ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,324Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 2343

$1.18M Total Retail Price of All Prescriptions

Rank: 64 out of 2343

759 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 759 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 759 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 12,871 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 824 596 1 4
LEVOTHYROXINE SODIUM 618 515 2 2
SIMVASTATIN 482 297 3 1
FUROSEMIDE 461 397 4 6
HYDROCODONE-ACETAMINOPHEN 443 305 S3 5 13
AMLODIPINE BESYLATE 443 384 5 5
METOPROLOL TARTRATE 436 360 7 7
LISINOPRIL 407 290 8 3
POTASSIUM CHLORIDE 357 308 9 18
MELOXICAM 343 260 10 68
GABAPENTIN 298 194 11 16
WARFARIN SODIUM 284 230 12 8
METFORMIN HCL 245 153 13 9
ATORVASTATIN CALCIUM 222 185 14 10
CITALOPRAM HBR 204 147 15 17
TAMSULOSIN HCL 198 170 16 29
METOPROLOL SUCCINATE 175 156 17 14
DONEPEZIL HCL 172 163 18 21
FAMOTIDINE 169 118 19 60
DIOVAN 161 147 20 23
CARVEDILOL 158 134 21 27
PREDNISONE 155 132 22 37
DIGOXIN 153 139 23 35
QUINAPRIL HCL 149 99 24 73
PANTOPRAZOLE SODIUM 147 123 25 22
ATENOLOL 145 136 26 12
PRANDIN 143 109 27 140
ZOLPIDEM TARTRATE 126 58 28 24
HYDROCHLOROTHIAZIDE 125 102 29 11
GLYBURIDE 125 69 R 29 62
SPIRIVA 125 84 29 48
DILTIAZEM 24HR ER 125 101 29 76
ADVAIR DISKUS 120 74 33 34
INDAPAMIDE 116 114 34 170
SERTRALINE HCL 113 61 35 20
PRAVASTATIN SODIUM 109 79 36 15
KLOR-CON M20 104 93 37 44
METFORMIN HCL ER 104 64 37 88
NAMENDA 102 93 39 36
PRAMIPEXOLE DIHYDROCHLORIDE 100 79 40 187
CLOPIDOGREL 100 67 40 26
ZETIA 98 82 42 52
ESCITALOPRAM OXALATE 96 70 43 55
FLUTICASONE PROPIONATE 93 68 44 46
ALLOPURINOL 89 77 45 31
FELODIPINE ER 84 81 46 116
PROAIR HFA 83 63 47 86
LOSARTAN POTASSIUM 83 64 47 19
CELEBREX 83 60 47 71
SINGULAIR 82 62 50 100
SYNTHROID 81 52 51 40
AZITHROMYCIN 80 60 52 39
PLAVIX 78 57 53 38
LYRICA 78 32 53 135
VENTOLIN HFA 77 25 55 79
TRAMADOL HCL 77 45 55 25
BUMETANIDE 76 74 57 91
ISOSORBIDE MONONITRATE ER 76 62 57 32
JANUVIA 72 41 59 50
THEOPHYLLINE ANHYDROUS 71 67 60 231
OXYCODONE-ACETAMINOPHEN 70 36 S2 61 49
DOXAZOSIN MESYLATE 69 67 62 98
ENALAPRIL MALEATE 68 43 63 58
OXYCODONE HCL 66 26 S2 64 67
SOTALOL 64 64 65 177
METHOTREXATE 64 52 65 235
CLONIDINE HCL 64 36 65 70
AMITRIPTYLINE HCL 63 60 R 68 117
CEFUROXIME 63 51 68 193
DILTIAZEM 24HR CD 63 61 68 83
TRAZODONE HCL 60 24 71 53
FENTANYL 60 41 S2 71 69
ALENDRONATE SODIUM 60 57 71 28
FINASTERIDE 60 47 71 80
LANTUS SOLOSTAR 59 47 75 101
TRICOR 58 31 76 96
DIOVAN HCT 58 56 76 63
GLIMEPIRIDE 57 57 78 45
METHOCARBAMOL 56 23 R 79 321
GLIPIZIDE XL 54 29 80 84
LOSARTAN-HYDROCHLOROTHIAZIDE 53 48 81 64
DILTIAZEM ER 52 50 82 207
CEPHALEXIN 52 32 82 111
PAROXETINE HCL 51 45 84 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.